Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

FinScreener

EUR/USD

1.1996

0.0039

0.33%

GBP/USD

1.3513

0.0000

0.00%

USD/JPY

111.57

0.0860

0.08%

USD/CHF

0.9622

0.0005

0.05%

EUR/GBP

0.8877

0.0029

0.32%

USD/CAD

1.2290

0.0010

0.09%

NZD/USD

0.7319

0.0060

0.83%

EUR/JPY

133.84

0.5395

0.40%

EUR/CHF

1.1543

0.0044

0.38%

Northwest Biotherapeutics Inc. Warrant

NASDAQ: NWBOW / / -
0.08-0.01-11.11%Vol 2001Y Perf -68.00%
Sep 14th, 2017 00:00
BID0.00 ASK0.00
Open0.08 Previous Close0.09
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date

Today's Price Range

0.080.08

 

52wk Range

0.080.58

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-33.33%
3 Months
-36.96%
6 Months
-29.82%
1 Year
-68.00%
3 Years
-97.24%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
NWBOW0.08-0.0100-11.11
AAPL158.730.06000.04
GOOG921.816.81000.74
MSFT75.440.28000.37
XOM80.220.13000.16
WFC53.360.65001.23
JNJ135.22-0.1600-0.12
FB172.522.51001.48
GE24.20-0.2600-1.06
JPM93.941.02001.10
...

TickerPriceChg.%52 Week High
LUK24.293.9427.33
KORS46.183.4352.67
NRG24.623.2726.25
AA46.202.8746.44
PGR47.632.8549.01
MGM32.562.7834.65
ALB134.652.77135.26
DE123.082.66132.50
NTAP41.712.6645.24
VZ49.342.6054.83
FCX14.482.4817.06
WYNN147.012.20147.50
T38.212.1143.03
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.00
Current Ratio 0.00
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -16.00
Leverage Ratio -1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-20 189.90
EBITDA Margin-20 135.80
Pre-tax Profit Margin-9 130.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)466.90
ROE last 12 Months 313.42
Return on Assets (5Y Avg) -181.15
ROA last 12 Months -170.82
Return on Capital (5Y Avg) -
ROC last 12 Months -
Return on invested Capital Q -
Return on invested Capital Y-
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)386
Revenue per Share -
Revenue Growth 3 Years -13.69
Revenue Growth 5 Years 2.81
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %0.00
Volume Overview
Volume200
Shares Outstanding (in ths.)0
Trades Count0
Dollar Volume0
Avg. Volume5 373
Avg. Weekly Volume4 860
Avg. Monthly Volume4 985
Avg. Quarterly Volume4 404

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

71%29%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x